Bioimmunoradiotherapy (Cetuximab/RT/Avelumab)

Clinical trial NCT02938273 · COMPLETED

Trial details

NCT number: NCT02938273
Sponsor: The Netherlands Cancer Institute
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Squamous Cell of Head and Neck

Start date: 2017-02-01
Primary completion: 2019-06-26
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.